NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sleep Number Corporation (NASDAQ: SNBR) on behalf of long-term stockholders. Our investigation concerns whether the board of directors of Sleep Number have breached their fiduciary duties to the company. Our investigation follows a securities class action […]
Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.--(BUSINESS WIRE)--$RBBN #RBBN--Shares of Ribbon Communications Inc. plunged nearly 23% on February 17, 2022, after the company revealed the day prior, in its Q4 report for 2021, that it was taking a goodwill write-down of $116 million. According to the Motley Fool, the company hadn’t mentioned […]
NEW YORK--(BUSINESS WIRE)--#AG--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Clariant AG (“Clariant” or the “Company”) (Other OTC: CLZNY) on behalf of Clariant stockholders. Our investigation concerns whether Clariant has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate […]
NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Acutus Medical Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB) in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or […]
NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) (NASDAQ: RETA) in the United States District Court for the Eastern District of Texas on behalf of all persons and entities who purchased […]
NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) (NASDAQ: RETA) in the United States District Court for the Eastern District of Texas on behalf of all persons and entities who purchased […]
SAN DIEGO--(BUSINESS WIRE)--#ASTRstock--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Astra Space Inc. f/k/a Holicity Inc. (NASDAQ: ASTR; HOL) publicly traded securities between February 2, 2021 and December 29, 2021, both dates inclusive (the “Class Period”) have until April 11, 2022 to seek appointment as lead plaintiff […]
SAN DIEGO--(BUSINESS WIRE)--$ELMS #classaction--Shareholder rights law firm Robbins LLP is investigating the officers and directors of Electric Last Mile Solutions, Inc. (NASDAQ: ELMS, ELMSW) f/k/a Forum Merger III Corp. (NASDAQ: FIII, FIIIU, FIIIW) for breaches of fiduciary duty and violations of the Securities Exchange Act of 1934. ELMS is a commercial electric vehicle solutions company […]
RICHMOND, Va.--(BUSINESS WIRE)--Whiteford, Taylor & Preston has announced that Robert R. Kaplan, Jr., has joined the firm in Richmond. With more than 20 years of experience in the securities sector, Mr. Kaplan is known as one of the leading lawyers in the Regulation A practice area. “We are very pleased to welcome Rob to the […]
CAMDEN, N.J.--(BUSINESS WIRE)--American Water Works Company, Inc. (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company, today announced that James H. Gallegos has been named the Executive Vice President and General Counsel effective April 1, 2022. Gallegos replaces Mike Sgro, who retired earlier in the month. “Jim is an outstanding addition to […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent